Clinical evaluation of pulsatile flow mode of Terumo Capiox centrifugal pump.
The Terumo Capiox centrifugal pump system possesses an automatic priming function in which the motor repeatedly stops and runs intermittently to eliminate air bubbles in the circuit through the micropores of the hollow-fiber membrane oxygenator. By modifying this mechanism, we have developed a pulsatile flow mode. In this mode, maximum and minimum pump rotational speeds can be independently set every 20 rpm in the range of 0 to 3,000 rpm. The duration of the pump run at maximum and minimum speeds can also be independently set every 0.1 s in the range of 0.2 to 15 s. In a clinical trial, after obtaining the desired flow rate, 2.4 L/min/m2 in nonpulsatile flow mode, a pulsatile flow mode of 60 cycles/min (with 1 cycle being maximum speed for 0.4 s and minimum speed for 0.6 s) was obtained by adding and subtracting 500 rpm to and from the rotational speed in nonpulsatile flow mode. Pulse pressures in the femoral artery and in the circuit just proximal to the perfusion cannula (6.5 mm Sarns high flow cannula with metal tip) were measured in 5 patients who underwent pulsatile cardiopulmonary bypass (CPB) for a coronary artery bypass graft (CABG), and compared to pulse pressures obtained by intraaortic balloon pumping (IABP) in 3 patients and by the pulsatile mode of the 3M Delphin pump in 3 patients. The platelet count, free hemoglobin, and beta-thromboglobulin (beta-TG) were measured and compared with measurements from another 5 patients who underwent nonpulsatile CPB. Although the pulse pressure measured in the circuit was 180 mm Hg on average, the pressure in the femoral artery was only 15 to 40 mm Hg with a mean of 20 mm Hg. In the same patients, 60 to 80 mm Hg pulse pressure was obtained with IABP. The pulse pressure obtained with the Delphin pump was not more than that obtained with the Terumo pump. There were no significant differences in percents of preoperative levels of platelet counts (pulsatile, 87.6 +/- 15.8% and nonpulsatile, 72.4 +/- 40.6%), free hemoglobin (pulsatile, 18 +/- 8 mg/dl and nonpulsatile, 25 = 7 mg/dl), and beta-TG (pulsatile 298 +/- 28 ng/ml and nonpulsatile, 312 +/- 143 ng/ml). In conclusion, although the pulsatile mode of the Terumo centrifugal pump did not exhibit any adverse effects hematologically, the pulse pressure obtained was unsatisfactorily small, mainly because of dumping caused by the perfusion cannula.
Nishida
H
H
Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical College, Japan.
Uesugi
H
H
Nishinaka
T
T
Uwabe
K
K
Aomi
S
S
Endo
M
M
Koyanagi
H
H
Oshiyama
H
H
Nogawa
A
A
Akutsu
T
T
D000787:Angina Pectoris / Q000601:surgery; D001783:Blood Flow Velocity / Q000502:physiology; D002315:Cardiopulmonary Bypass / Q000592:standards; D002498:Centrifugation; D001026:Coronary Artery Bypass / Q000592:standards; D003327:Coronary Disease / Q000601:surgery; D006353:Heart-Assist Devices / Q000592:standards*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007423:Intra-Aortic Balloon Pumping / Q000592:standards; D008297:Male; D008875:Middle Aged; D010107:Oxygenators, Membrane / Q000592:standards*; D010976:Platelet Count; D011673:Pulsatile Flow / Q000502:physiology*; D016277:Ventricular Function, Left; D001620:beta-Thromboglobulin / Q000378:metabolism
D006454:Hemoglobins; D001620:beta-Thromboglobulin